CEP55 Matched Antibody Pair (260) (APMAB-260LY)

Huang, R. H., Yang, W. K., Wu, C. M., Yeh, C. M., & Sung, W. W. (2021). Over-expression of CEP55 predicts favorable prognosis in colorectal cancer patients with lymph node involvement. Anticancer Research, 41(1), 543-547.

Tandon, D., & Banerjee, M. (2020). Centrosomal protein 55: A new paradigm in tumorigenesis. European Journal of Cell Biology, 99(5), 151086.

Rawlins, L. E., Jones, H., Wenger, O., Aye, M., Fasham, J., Harlalka, G. V., ... & Baple, E. L. (2019). An Amish founder variant consolidates disruption of CEP55 as a cause of hydranencephaly and renal dysplasia. European Journal of Human Genetics, 27(4), 657-662.

Yanagi, K., Sone, R., Ohga, R., & Kawahara, A. (2019). Involvement of the centrosomal protein 55 (cep55) gene in zebrafish head formation. Genes to Cells, 24(10), 642-649.

Li, F., Jin, D., Guan, L., Zhang, C. C., Wu, T., Wang, Y. J., & Gao, D. S. (2019). CEP55 promoted the migration, invasion and neuroshpere formation of the glioma cell line U251. Neuroscience letters, 705, 80-86.

Ma, X. P., Zhang, W., Wu, B. Q., & Qin, J. (2018). Correlations between mRNA levels of centrosomal protein 55 (CEP55) and clinical features of patients with lung cancer. Medical science monitor: international medical journal of experimental and clinical research, 24, 3093.

Qi, J., Liu, G., & Wang, F. (2018). High levels of centrosomal protein 55 expression is associated with poor clinical prognosis in patients with cervical cancer. Oncology letters, 15(6), 9347-9352.

Zhu, H., Chen, D., Tang, J., Huang, C., Lv, S., Wang, D., & Li, G. (2018). Overexpression of centrosomal protein 55 regulates the proliferation of glioma cell and mediates proliferation promoted by EGFRvIII in glioblastoma U251 cells. Oncology letters, 15(2), 2700-2706.

Peng, T., Zhou, W., Guo, F., Wu, H. S., Wang, C. Y., Wang, L., & Yang, Z. Y. (2017). Centrosomal protein 55 activates NF-κB signalling and promotes pancreatic cancer cells aggressiveness. Scientific reports, 7(1), 1-12.

Jiang, W., Wang, Z., & Jia, Y. (2017). CEP55 overexpression predicts poor prognosis in patients with locally advanced esophageal squamous cell carcinoma. Oncology letters, 13(1), 236-242.

Please try the standard protocols which include: protocols, troubleshooting and guide.

Enzyme-linked Immunosorbent Assay (ELISA)
Flow Cytometry
Immunofluorescence (IF)
Immunohistochemistry (IHC)
Immunoprecipitation (IP)
Western Blot (WB)
Enzyme-Linked Immunospot (ELISpot)
Proteogenomics
Other Protocols

Related Products

Mouse Anti-CEP55 Recombinant Antibody (6B1) (CAT#: CBMAB-C8070-LY)

Mouse Anti-CEP55 Recombinant Antibody (CBWJC-2025) (CAT#: CBMAB-C2619WJ)

Mouse Anti-CEP55 Recombinant Antibody (CP0285) (CAT#: CBMAB-CP0285-LY)

Rabbit Anti-CEP55 Recombinant Antibody (EG651) (CAT#: CBMAB-EN784-LY)

Mouse Anti-CEP55 Recombinant Antibody (CBFYC-1725) (CAT#: CBMAB-C1787-FY)

Mouse Anti-CEP55 Recombinant Antibody (CBWJC-2498) (CAT#: CBMAB-C3568WJ)

Isotype control